Navigation Links
Medarex to Receive Milestone Payment from MedImmune for Allowance of an Investigational New Drug Application for MEDI-546
Date:2/2/2009

or itself and its partners. Over forty of these therapeutic product candidates derived from Medarex technology are in human clinical testing or have had INDs submitted for such trials, with the most advanced product candidates currently in Phase 3 clinical trials, the subject of regulatory applications for marketing authorization or approved in Canada and Europe. Medarex is committed to building value by developing a diverse pipeline of antibody products to address the world's unmet healthcare needs. For more information about Medarex, visit its website at www.medarex.com.

Statement on Cautionary Factors

Except for the historical information presented herein, matters discussed herein may constitute forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995, that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Statements that are not historical facts, including statements preceded by, followed by, or that include the words "potential" or "may" or similar statements are forward-looking statements. Medarex disclaims, however, any intent or obligation to update these forward-looking statements. These risks and uncertainties include those detailed from time to time in Medarex's public disclosure filings with the U.S. Securities and Exchange Commission (SEC), including its Annual Report on Form 10-K for the fiscal year ended December 31, 2007 and its quarterly reports on Form 10-Q. There can be no assurance that such development efforts will succeed or that other developed products will receive required regulatory clearance or that, even if such regulatory clearance were received, such products would ultimately achieve commercial success. Copies of Medarex's public disclosure filings are available from its inve
'/>"/>

SOURCE Medarex, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Medarex Reviews Recent Highlights and Outlook for 2009
2. Medarex to Receive Milestone Payment for Approval of STELARA(TM) (Ustekinumab) for the Treatment of Moderate to Severe Plaque Psoriasis
3. Medarex Hosts June 2nd Webcast of Ipilimumab Data Presented at ASCO
4. Medarex Announces 2008 First Quarter Financial Results
5. Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab
6. Medarex Announces 2007 Fourth Quarter and Year End Financial Results
7. Medarex to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
8. Medarex to Receive Milestone Payment for Submission of Regulatory Applications Requesting Approval of Ustekinumab (CNTO 1275) for Treatment of Psoriasis
9. PharmAthene and Medarex Announce Additional $0.8 Million U.S. Government Appropriation for Continued Development of Anthrax Therapeutic Valortim(TM)
10. Medarex to Present at the JPMorgan Small/Mid Cap Conference
11. Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti-PD1 Antibody
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... decade, the United Nations Foundation has led the fight ... World Malaria Report 2009 that the global strategies for ending malaria ... Health for the United Nations Foundation , ... Washington, ... United Nations Foundation has led the fight against malaria, ...
(Date:12/15/2009)... developmental changes increases risk in teens, study suggests , , ... overweight or obese increases the risk of obstructive sleep ... true for younger children, Australian researchers have found. , ... 2 to 18, who were referred for evaluation of ... that among those aged 12 and older the risk ...
(Date:12/15/2009)... Program, a new employment opportunity for the unemployed or those needing ... opportunities in America today. , ... Orlando, FL (PRWEB) ... successful collection agencies, is spreading holiday cheer and good will that ... RPS has created an opportunity for out of work Americans to ...
(Date:12/15/2009)... injury when doctors decide benefits of imaging outweigh the ... scans can pose a serious risk to people with ... Administration researchers exposed pacemakers to a simulated MRI magnetic ... the tip of the pacemaker lead, where it would ... exposure to MRI magnetic pulses caused certain pacemakers to ...
(Date:12/15/2009)... a surgical method, with fewer complications, analysis finds, , , ... to diagnosing breast cancer, women and their doctors have ... invasive "core needle biopsy" procedure is nearly as effective ... is, with fewer complications than the surgical version. , ... 5 issue of Annals of Internal Medicine , ...
Breaking Medicine News(10 mins):Health News:Statement by Dr. Daniel Carucci, Vice President for Global Health for the United Nations Foundation, on Progress Shown in World Malaria Report 2009 2Health News:Puberty May Trigger Sleep Apnea in Overweight Kids 2Health News:RPS Worldwide Launches Affiliate Program -- The Collection Agency That Gives Christmas Back, Rather Than Take it Away 2Health News:RPS Worldwide Launches Affiliate Program -- The Collection Agency That Gives Christmas Back, Rather Than Take it Away 3Health News:Patients With Pacemakers Should Avoid MRI Scans 2Health News:Needle Biopsy Works Well in Diagnosing Breast Cancer 2
... SANTA CRUZ, Calif., Sept. 19 The ShirleyBOARD ... Web Marketing,Association (WMA) for Outstanding Achievement in Website ... of Excellence WebAward,Designation. ShirleyBOARD is a free ... caring for aging loved ones stay organized and ...
... 19 The Coalition for,Fairness in Mental Illness Coverage ... Mental Health Parity Act of 2007, setting the stage ... because of the,leadership of Senators Pete V. Domenici (R-NM), ... will make mental health and substance use,disorder insurance coverage ...
... HealthDATA, the industry,s,only end-to-end resource for comprehensive market ... completed the updates to their Long Term,Care and ... updated,information about the facilities and their corporate parents, ... number of overall contacts compared to,the prior year. ...
... Mass., Sept. 19 Hologic, Inc.,(Nasdaq: HOLX ) ... presenting at the UBS Global Life Sciences Conference being ... Hotel in New York, NY. Interested parties are ... investor presentation on Wednesday, September 26, 2007 at 4:30,p.m. ...
... with Oxford Journals, and the Japanese Society of Medical ... which will result in ESMOs official journal Annals of ... society. , Annals of Oncology is fully owned by ... the journal will be endorsed by JSMO and all ...
... living with cancer or have survived it, one factor ... communication. In recognition of this, the National Cancer Institute ... co-authored by a University of Rochester physician, stating that ... and deserves more research. , Without the ability to ...
Other Medicine News:Health News:Elder Caregiving Site ShirleyBOARD.com Wins WebAward for Outstanding Online Community 2Health News:Billian's HealthDATA Completes Comprehensive Long Term Care Database Update 2Health News:ESMO, Oxford Journals and the Japanese Society of Medical Oncology announce collaboration 2Health News:Communication in cancer world is key to survival 2
(Date:12/15/2009)... 15 OrthoWorx, the newly formed industry, community ... device sector in Kosciusko County, is working to connect ... like Chicago and Cleveland via high-speed rail. ,, In ... The Orthopedics Capital of the World -- An ... growth, BioCrossroads, the statewide initiative to grow ...
(Date:12/15/2009)... Dakim, Inc. and Alzheimer,s Weekly today announced ... Brain Health Contest, designed to help five seniors in ... Alzheimer,s disease. All five winners will receive a $2,500 ... help seniors preserve their brain health and the most ... communities across the country. ,, The contest, ...
(Date:12/15/2009)... Dec. 15 Medical researchers with EDP ... their revolutionary new technology for a simple blood ... ,, Following the success of its pre-clinical trials ... patent on the biomarker, CA11-19, and all aspects ... test, ColoMarker(TM) will detect colon cancer in its ...
Breaking Medicine Technology:OrthoWorx Urges Warsaw's Inclusion on High-Speed Rail Corridor Connecting Chicago and Cleveland 2OrthoWorx Urges Warsaw's Inclusion on High-Speed Rail Corridor Connecting Chicago and Cleveland 35 Seniors Win $2,500 Dakim BrainFitness System to Fight Alzheimer's 25 Seniors Win $2,500 Dakim BrainFitness System to Fight Alzheimer's 3Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer 221st International Radon Symposium 57111 121st International Radon Symposium 57111 2eClinicalWorks Utilizes EMC to Manage Business Expansion and Reduce Costs 57108 1eClinicalWorks Utilizes EMC to Manage Business Expansion and Reduce Costs 57108 2eClinicalWorks Utilizes EMC to Manage Business Expansion and Reduce Costs 57108 3JEWEL OSCO PHARMACY Offers Grocery Savings to Flu Shot Customers 57105 1JEWEL OSCO PHARMACY Offers Grocery Savings to Flu Shot Customers 57105 2
... Collaborative Research Agreement With The University of Texas M. D., ... ... Cancer, VEDBAEK, Denmark, May ... today,announces that it has signed a collaborative research agreement with the,Kleberg Center ...
... and Only Treatment for Hunter Syndrome Now Approved in 40 ... ... Worldwide, BASINGSTOKE, England and CAMBRIDGE, Massachusetts, May 27, ... announced that ELAPRASE(R),(idursulfase), a human enzyme replacement therapy for the ...
Other Medicine Technology:Exiqon Forms Research Collaboration With M. D. Anderson Cancer Center 2Exiqon Forms Research Collaboration With M. D. Anderson Cancer Center 3Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 2Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 3Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 4Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 5
Incontinence Pessaries...
Indications: for young women who experience stress urinary incontinence when excercising vigorously; i.e., aerobics, tennis, jogging....
... pessary is designed for third ... well as a cystocele and ... available both with and without ... silicone tie to aid in ...
The Mar-Land is used for stress incontinence and minor prolapse. It is available both with and without support in seven different sizes....
Medicine Products: